. . . . . . . "[RHAMM/CD168 R3-peptide (ILSLELMKL) -specific T-cell responses in chronic myeloid leukemia [CML]patients were demonstrated; vaccination strategies inducing such RHAMM-R3-directed effector T cells might enhance specific immune responses against CML cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2009-03-31"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:25+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .